Dr. Carter’s research program focuses on host immune responses to viral infection and vaccination, with an emphasis on defining the innate and early immune mechanisms that shape downstream antiviral immunity. Her work integrates experimental approaches in molecular biology and immunology to investigate fundamental questions in host–virus interactions, including the sensing of viral components and activation of effector responses. Ongoing and future projects aim to characterize how viral stimuli and immune signaling influence the magnitude and quality of immune responses, with implications in antiviral defense and informed vaccine design.
Contact Information
Assistant Professor of Biology
Research & Clinical Interests
Education
PhD, Immunology & Microbial Pathogenesis, Thomas Jefferson University, Philadelphia, PA - 2023
BS, Biochemistry, Cell & Molecular Biology and Philosophy, University of Scranton, Scranton, PA - 2017
Publications
- Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease
- Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge
- Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity
- Tetravalent Rabies-Vectored Filovirus and Lassa Fever Vaccine Induces Long-term Immunity in Nonhuman Primates